A Pandemic of the Triple Vaccinated


During a CNN Town Hall event on July 21, 2021, President Joe Biden said: “If you’re vaccinated, you’re not going to be hospitalized, you’re not going to be in an ICU unit, and you are not going to die.” 

On May 16, 2021, Dr. Anthony Fauci claimed that vaccination did not just protect the individual, but also the community, because “by preventing the spread of the virus … you become a dead end to the virus. And when there are a lot of dead ends around, the virus is not going to go anywhere.” 

Relying in the judgment of his chief medical adviser, Biden took to talking about the pandemic of the unvaccinated in a two-track effort both to encourage vaccine takeup and to vilify, demonize and shame those who remained uncertain enough of the balance of benefits and short and long-term risks of the rushed Covid-19 vaccines to avoid succumbing to the multiple pressures to go along with the zeitgeist in order to get along with everyone.

We have now had both Dr. Fauci, the public face of the US management of the pandemic, revered in some quarters and reviled in others, and President Biden himself get infected with Covid, despite both being double-vaccinated and double-boosted. 

Inevitably, to try and stop the official narrative on the benefits of the vaccine from unraveling completely and in order to encourage continuing vaccine and boosters takeup, they insist that their updated vaccination status helped to limit the severity of their infection. This is based on a cult-like faith, akin to self-validating and self-canceling explanations put forth by astrologers for predictions that come true and don’t, as the case may be. 

Although on July 20, Fauci admitted that the data do make it clear that “vaccines – because of the high degree of transmissibility of this virus – don’t protect overly well, as it were, against infection.” Robert F. Kennedy Jr. asked why the media was not holding Fauci “accountable for the costly national policies and the lockdowns that were utterly built upon his initial assertion that the vaccines would prevent transmission and end the pandemic.” 

Equally, of course, one must ask again: if vaccines don’t stop transmission, how does the government justify vaccination mandates for travel to the US?

In a matching vein, the New South Wales (NSW) Health report for the week ending 16 July claims that: “The minority of the overall population who have not been vaccinated are significantly overrepresented among patients in hospitals and ICUs with Covid-19.” 

The following challenges that claim using their own data.

By drawing on the distinction between the efficacy and effectiveness of vaccines, it’s possible to argue that in NSW, rather than a pandemic of the unvaccinated, what we have witnessed is a pandemic of the triple-vaccinated.

NSW health facts

In September 2021, NSW had 844 staffed ICU beds, of which 173 (20.5 percent) were occupied by Covid-19 patients. (Australia-wide, the number of ICU beds is 2,183.) By January 2022, the number had increased to around 1,000. If necessary, this can be bumped up further by utilizing the limited number of ICU beds in private hospitals. 

There are 9,500 general ward beds in public and another 3,000 beds in private hospitals in NSW. In mid-July 2022, there were 2,058 people in hospital with Covid-19 in NSW, or 21.7 percent of the public system’s capacity and 16.5 percent of the state’s total hospital beds capacity. An additional 6,500 people were in hospital for non-Covid reasons.

During the week of July 10–16, a total of 806 people were admitted to hospital with Covid-19, another 77 into ICU, and 142 people died with Covid-19 illness (though not necessarily as the primary cause of death). Moreover, of the 142 deaths, only four were aged below 60, so that people aged 60 and above accounted for 97.2 percent of all Covid-related deaths in the state. 

Additionally, of the 142 dead, the vaccination status of 2 was not known. One hundred and eighteen of the remaining 140 – 84.3 percent – were at least double-vaccinated and 69 had received three doses of the vaccine: by far the biggest single cohort and almost equal to all the others combined. Hence the thought that perhaps what we are experiencing is a pandemic of the triple-vaccinated.

Efficacy vs. effectiveness

The Cambridge Dictionary defines efficacy as “how well a particular treatment or drug works under carefully controlled scientific testing conditions.” By contrast, effectiveness is defined as “how well a particular treatment or drug works when people are using it, as opposed to how well it works under carefully controlled scientific testing conditions.” 

Thus doubts about the effectiveness of a new product in treating any disease can only be resolved once the vaccine is widely available and administered in the target population. GAVI (the Global Alliance for Vaccines and Immunization), now called Gavi, the Vaccine Alliance, is a partnership between the World Health Organization, Unicef, the World Bank and the Bill & Melinda Gates Foundation. 

Writing for GAVI, Priya Joi offers similar definitions, describing “efficacy” as the measure of how much a vaccine prevents infection (and possibly also transmission) under ideal, controlled conditions where a vaccinated group is compared with a placebo group. She adds: “Vaccines do not always need to have an exceptionally high effectiveness to be useful, for example the influenza vaccine is 40-60% effective yet saves thousands of lives every year.”

Examining the percentage of the thrice-jabbed in hospital admissions, ICU beds, and dead against the baseline of their share in the overall population, preferably age-adjusted, is critical to calculating vaccine efficacy. I’m not sure how helpful that is to assessing the effectiveness of vaccines in keeping the absolute numbers down below the state’s or country’s capacity thresholds of hospital and ICU beds.

If the primary public health justification for universal vaccination is to reduce the burden on the health infrastructure and prevent hospitals and ICU capacity from being overwhelmed – which was indeed the main justification in the language of two-three weeks to flatten the curve – then the key question becomes: How effective are the vaccines in preventing hospital admissions and ICU occupancy? Their role in preventing infection by itself is less important than their effectiveness in controlling the severity of the disease.

For example, a report from the Dutch health ministry found that the effectiveness of two doses of vaccines after one year had fallen overall to 0 percent against hospitalizations and minus 20 percent against ICU admission. Perhaps more pertinently in relation to NSW, Dr. Eyal Shahar notes signs in Israel of a short-term fatality rate of a third dose.

Efficacy is more helpful to an individual in assessing the relative risk of infection if vaccinated or not. Because Covid vaccines were granted emergency-use authorization and long-term efficacy and safety profiles were simply not available, doubts have persisted about the integrity, credibility and long-term reliability of data and results from the trials conducted by the vaccine manufacturers. 

Moreover, as we’ve been made aware with respect to the UK, different branches of the government like the Health Security Agency and the Office of National Statistics use different and hotly contested methodologies for calculating the numbers and proportions of the population infected by Covid, which in turn determines the estimated infection fatality rate (IFR). 

In any case, even if we agree that the IFR and case fatality rate (CFR) of flu and Covid are broadly comparable by now, the scale and magnitude of Covid means that similar IFR and CFR still produce vastly different orders of challenges for public health policy.

By contrast the effectiveness of the vaccines for controlling hospital admissions, ICU bed occupancy and mortality is measured by solid and reliable information that is both accurate and comprehensive in Western countries. This makes vaccine effectiveness a better policy tool for deciding on population-wide mandates while efficacy might be the more relevant for informed individual decisions.